Group One Trading’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.6K | Buy |
+1,500
| New | +$40.9K | ﹤0.01% | 5295 |
|
|
2025
Q4 | – | Sell |
-13,000
| Closed | -$336K | – | 8440 |
|
|
2025
Q3 | $336K | Buy |
13,000
+7,600
| +141% | +$176K | 0.01% | 4120 |
|
|
2025
Q2 | $110K | Sell |
5,400
-300
| -5% | -$5.84K | ﹤0.01% | 4886 |
|
|
2025
Q1 | $103K | Buy |
5,700
+4,900
| +613% | +$109K | ﹤0.01% | 4577 |
|
|
2024
Q4 | $20.2K | Sell |
800
-10,800
| -93% | -$293K | ﹤0.01% | 5680 |
|
|
2024
Q3 | $394K | Buy |
11,600
+3,500
| +43% | +$133K | 0.02% | 3038 |
|
|
2024
Q2 | $300K | Sell |
8,100
-4,200
| -34% | -$158K | 0.01% | 3049 |
|
|
2024
Q1 | $516K | Sell |
12,300
-27,400
| -69% | -$1.13M | 0.02% | 2697 |
|
|
2023
Q4 | $1.57M | Buy |
39,700
+30,200
| +318% | +$888K | 0.05% | 2072 |
|
|
2023
Q3 | $261K | Sell |
9,500
-3,200
| -25% | -$100K | 0.01% | 3572 |
|
|
2023
Q2 | $431K | Buy |
12,700
+2,500
| +25% | +$84.3K | 0.02% | 3174 |
|
|
2023
Q1 | $367K | Sell |
10,200
-69,900
| -87% | -$3.02M | 0.02% | 3053 |
|
|
2022
Q4 | $3.57M | Buy |
80,100
+2,200
| +3% | +$78.5K | 0.12% | 1372 |
|
|
2022
Q3 | $2.19M | Sell |
77,900
-16,000
| -17% | -$491K | 0.07% | 1835 |
|
|
2022
Q2 | $2.53M | Buy |
93,900
+22,400
| +31% | +$651K | 0.07% | 1839 |
|
|
2022
Q1 | $2.44M | Sell |
71,500
-16,400
| -19% | -$524K | 0.05% | 2214 |
|
|
2021
Q4 | $3.4M | Buy |
87,900
+2,300
| +3% | +$100K | 0.06% | 2063 |
|
|
2021
Q3 | $4.62M | Buy |
85,600
+13,600
| +19% | +$638K | 0.1% | 1777 |
|
|
2021
Q2 | $2.41M | Sell |
72,000
-52,800
| -42% | -$1.45M | 0.05% | 2441 |
|
|
2021
Q1 | $2.57M | Buy |
124,800
+52,400
| +72% | +$1.2M | 0.06% | 2183 |
|
|
2020
Q4 | $1.27M | Buy |
72,400
+57,300
| +379% | +$1.03M | 0.04% | 2436 |
|
|
2020
Q3 | $224K | Sell |
15,100
-6,500
| -30% | -$76.1K | 0.01% | 3562 |
|
|
2020
Q2 | $281K | Buy |
+21,600
| New | +$95.7K | 0.02% | 3104 |
|
|
2019
Q4 | – | Sell |
-24,000
| Closed | -$51K | – | 5283 |
|
|
2019
Q3 | $51K | Buy |
24,000
+20,000
| +500% | +$46.3K | ﹤0.01% | 3956 |
|
|
2019
Q2 | $11K | Buy |
+4,000
| New | +$13.6K | ﹤0.01% | 4382 |
|
|
2018
Q3 | – | Sell |
-2,247
| Closed | -$17K | – | 5332 |
|
|
2018
Q2 | $17K | Buy |
2,247
+67
| +3% | +$896 | ﹤0.01% | 4430 |
|
|
2018
Q1 | $76K | Sell |
2,180
-6,013
| -73% | -$233K | 0.01% | 3417 |
|
|
2017
Q4 | $349K | Buy |
8,193
+6,833
| +502% | +$293K | 0.02% | 2538 |
|
|
2017
Q3 | $58K | Sell |
1,360
-3,620
| -73% | -$136K | ﹤0.01% | 3550 |
|
|
2017
Q2 | $185K | Buy |
4,980
+1,353
| +37% | +$59.8K | 0.01% | 2697 |
|
|
2017
Q1 | $196K | Sell |
3,627
-3,406
| -48% | -$177K | 0.01% | 2535 |
|
|
2016
Q4 | $373K | Sell |
7,033
-2,754
| -28% | -$157K | 0.02% | 1976 |
|
|
2016
Q3 | $593K | Sell |
9,787
-653
| -6% | -$40.7K | 0.04% | 1690 |
|
|
2016
Q2 | $687K | Buy |
10,440
+1,033
| +11% | +$65.6K | 0.06% | 1503 |
|
|
2016
Q1 | $533K | Sell |
9,407
-22,793
| -71% | -$2.56M | 0.06% | 1632 |
|
|
2015
Q4 | $7.57M | Sell |
32,200
-14,587
| -31% | -$3.18M | 0.61% | 230 |
|
|
2015
Q3 | $7.4M | Sell |
46,787
-13,333
| -22% | -$3.77M | 0.69% | 222 |
|
|
2015
Q2 | $22.7M | Buy |
60,120
+8,227
| +16% | +$3.27M | 2.08% | 44 |
|
|
2015
Q1 | $21.7M | Buy |
51,893
+24,260
| +88% | +$8.68M | 2.32% | 36 |
|
|
2014
Q4 | $7.57M | Buy |
27,633
+9,046
| +49% | +$2.25M | 0.75% | 174 |
|
|
2014
Q3 | $3.61M | Sell |
18,587
-7,206
| -28% | -$1.57M | 0.3% | 407 |
|
|
2014
Q2 | $6.31M | Buy |
25,793
+3,226
| +14% | +$728K | 0.59% | 223 |
|
|
2014
Q1 | $5.98M | Buy |
22,567
+7,020
| +45% | +$2.69M | 0.62% | 176 |
|
|
2013
Q4 | $5.65M | Buy |
15,547
+1,594
| +11% | +$614K | 0.6% | 227 |
|
|
2013
Q3 | $7.42M | Buy |
13,953
+7,766
| +126% | +$2.66M | 0.96% | 122 |
|
|
2013
Q2 | $1.45M | Buy |
+6,187
| New | +$1.22M | 0.23% | 595 |
|
Other funds holding CLDX
KCM
VCM
CC
EP